MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$5,849,734
EPS
-$0.2
Unit: Dollar

Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
General and administrative
1,152,996 1,136,709 328,510* 1,754,856
Research and development
475,064 109,434 -210,527* 158,699
Total operating expenses
1,628,060 1,246,143 117,983 1,913,555
Loss from operations
-1,628,060 -1,246,143 -117,983* -1,913,555
Net loss from change in fair value of derivative liability instrument
-3,341,568 697,561 2,487,591.5* -
Gain from change in fair value of forward contract liability
---95,110.5* -
Amortization of deferred offering cost
638,747 477,647 124,237* -
Interest income
-49,679 14,250* 5,111
Other income
-5,578 163,740* 4,260
Interest income (expense), net
-241,359 ---
Total other income (expense)
-4,221,674 275,171 2,636,455* 9,371
Net gain
-5,849,734 -970,972 2,518,472 -1,904,184
Basic EPS
-0.2 -0.03 0.092 -0.07
Diluted EPS
-0.2 -0.03 0.092 -0.07
Basic Average Shares
29,788,040 29,476,002 27,456,883 27,975,207
Diluted Average Shares
29,788,040 29,476,002 27,456,883 27,975,207
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net gain-$5,849,734 Total other income(expense)-$4,221,674 Loss from operations-$1,628,060 Net loss from changein fair value of...-$3,341,568 Amortization of deferredoffering cost$638,747 Interest income(expense), net-$241,359 Total operatingexpenses$1,628,060 General andadministrative$1,152,996 Research and development$475,064

Turn Therapeutics Inc. (TTRX)

Turn Therapeutics Inc. (TTRX)